7
Orphan Designations
0
FDA Approvals
15
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Burkitt lymphoma | 6,8-bis(benzylthio)octanoic acid | Orphan Designation | - |
| Kaposi's sarcoma | Devimistat | Orphan Designation | - |
| acute myeloid leukemia | 6,8-bis-benzylsulfanyl-octanoic acid | Orphan Designation | - |
| carcinoma of liver and intrahepatic biliary tract | devimistat | Orphan Designation | - |
| clear cell sarcoma | Devimistat | Orphan Designation | - |
| colon Burkitt lymphoma | 6,8-bis(benzylthio)octanoic acid | Orphan Designation | - |
| combined hepatocellular carcinoma and cholangiocarcinoma | devimistat | Orphan Designation | - |
| enteropathy-associated T-cell lymphoma | devimistat | Orphan Designation | - |
| hepatocellular carcinoma | devimistat | Orphan Designation | - |
| malignant pancreatic neoplasm | 6,8-bis-benzylsulfanyl-octanoic acid | Orphan Designation | - |
| mature T-cell and NK-cell non-Hodgkin lymphoma | devimistat | Orphan Designation | - |
| myelodysplastic syndrome | devimistat | Orphan Designation | - |
| peripheral T-cell lymphoma, not otherwise specified | devimistat | Orphan Designation | - |
| small intestinal Burkitt lymphoma | 6,8-bis(benzylthio)octanoic acid | Orphan Designation | - |
| soft tissue sarcoma | Devimistat | Orphan Designation | - |